Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2017 · limited partnership

$1.8bn reported value +20.9% vs Q1 2026
115positions
46.6%in top 10
32 new 37 added 39 reduced 21 sold out vs Q1 2026

Options: 2 call positions ($13.0m notional), 3 put positions ($80.3m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 287,668 $155.9m8.50% 8.50% AddedShares held: Q3 2025 253.2k, Q4 2025 252.6k, Q1 2026 264.3k, Q2 2026 287.7k +23.4k +23,397 8.8%
2 ABIVAX SA SPONSORED ADS ABVX ABVX 913,880 $121.8m6.64% 6.64% ReducedShares held: Q3 2025 426.5k, Q4 2025 657.8k, Q1 2026 934.4k, Q2 2026 913.9k -20.5k -20,543 -2.2%
3 ENCOMPASS HEALTH CORP COM EHC EHC 1,026,919 $103.8m5.66% 5.66% AddedShares held: Q3 2025 0, Q4 2025 106.9k, Q1 2026 194.1k, Q2 2026 1.0m +832.8k +832,815 429.1%
4 ENSIGN GROUP INC COM ENSG ENSG 602,079 $96.5m5.26% 5.26% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.8k, Q2 2026 602.1k +587.3k +587,318 3978.8%
5 VERA THERAPEUTICS INC CL A VERA VERA 2,212,770 $94.9m5.18% 5.18% AddedShares held: Q3 2025 2.8m, Q4 2025 3.1m, Q1 2026 2.2m, Q2 2026 2.2m +39.5k +39,484 1.8%
6 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,785,941 $66.5m3.62% 3.62% ReducedShares held: Q3 2025 1.2m, Q4 2025 1.4m, Q1 2026 1.8m, Q2 2026 1.8m -2.1k -2,075 -0.1%
7 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,798,210 $61.2m3.33% 3.33% ReducedShares held: Q3 2025 3.5m, Q4 2025 3.3m, Q1 2026 2.9m, Q2 2026 2.8m -87.4k -87,412 -3.0%
8 BROOKDALE SR LIVING INC COM BKD BKD 3,396,470 $54.6m2.98% 2.98% ReducedShares held: Q3 2025 0, Q4 2025 374.9k, Q1 2026 3.6m, Q2 2026 3.4m -172.1k -172,085 -4.8%
9 IONIS PHARMACEUTICALS INC COM IONS IONS 664,684 $52.7m2.87% 2.87% AddedShares held: Q3 2025 538.7k, Q4 2025 538.2k, Q1 2026 632.1k, Q2 2026 664.7k +32.6k +32,584 5.2%
10 NATERA INC COM NTRA NTRA 175,807 $47.7m2.60% 2.60% ReducedShares held: Q3 2025 519.6k, Q4 2025 334.5k, Q1 2026 384.7k, Q2 2026 175.8k -208.9k -208,906 -54.3%
11 TRAVERE THERAPEUTICS INC COM TVTX TVTX 798,973 $45.4m2.47% 2.47% AddedShares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 542.6k, Q2 2026 799.0k +256.4k +256,363 47.2%
12 CARETRUST REIT INC COM CTRE CTRE 1,072,015 $43.3m2.36% 2.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
13 HCA HEALTHCARE INC COM HCA HCA 98,252 $38.3m2.09% 2.09% AddedShares held: Q3 2025 111.7k, Q4 2025 95.9k, Q1 2026 79.2k, Q2 2026 98.3k +19.0k +19,023 24.0%
14 VAXCYTE INC COM PCVX PCVX 629,952 $36.6m2.00% 2.00% ReducedShares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 924.2k, Q2 2026 630.0k -294.2k -294,241 -31.8%
15 LIQUIDIA CORPORATION COM NEW LQDA LQDA 428,652 $34.2m1.86% 1.86% ReducedShares held: Q3 2025 486.0k, Q4 2025 509.4k, Q1 2026 677.4k, Q2 2026 428.7k -248.7k -248,740 -36.7%
16 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,864,575 $26.3m1.43% 1.43% ReducedShares held: Q3 2025 7.0m, Q4 2025 7.9m, Q1 2026 8.7m, Q2 2026 7.9m -812.7k -812,706 -9.4%
17 GSK PLC SPONSORED ADR GSK GSK 481,833 $25.3m1.38% 1.38% ReducedShares held: Q3 2025 2.1m, Q4 2025 2.7m, Q1 2026 1.8m, Q2 2026 481.8k -1.3m -1,303,342 -73.0%
18 CHEMED CORP NEW COM CHE CHE 52,523 $24.5m1.33% 1.33% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 31.1k, Q2 2026 52.5k +21.5k +21,466 69.1%
19 ELI LILLY & CO COM LLY LLY 20,116 $24.1m1.32% 1.32% AddedShares held: Q3 2025 0, Q4 2025 10.6k, Q1 2026 19.0k, Q2 2026 20.1k +1.1k +1,116 5.9%
20 GERON CORP COM GERN GERN 18,717,422 $24.0m1.31% 1.31% ReducedShares held: Q3 2025 12.6m, Q4 2025 17.7m, Q1 2026 18.8m, Q2 2026 18.7m -117.5k -117,461 -0.6%
21 VIKING THERAPEUTICS INC COM VKTX VKTX 602,922 $23.5m1.28% 1.28% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 239.1k, Q2 2026 602.9k +363.8k +363,812 152.2%
22 OMEGA HEALTHCARE INVS INC COM OHI OHI 483,547 $23.1m1.26% 1.26% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 585.7k, Q2 2026 483.5k -102.1k -102,133 -17.4%
23 INSULET CORP COM PODD PODD 148,816 $22.7m1.24% 1.24% AddedShares held: Q3 2025 45.6k, Q4 2025 74.7k, Q1 2026 143.5k, Q2 2026 148.8k +5.3k +5,270 3.7%
24 TENET HEALTHCARE CORP COM NEW THC THC 114,199 $21.4m1.16% 1.16% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 29.5k, Q2 2026 114.2k +84.7k +84,687 287.0%
25 UNITEDHEALTH GROUP INC COM UNH UNH 51,145 $21.3m1.16% 1.16% NewShares held: Q3 2025 62.8k, Q4 2025 60.9k, Q1 2026 0, Q2 2026 51.1k
26 WELLTOWER INC COM WELL WELL 87,312 $19.8m1.08% 1.08% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 181.0k, Q2 2026 87.3k -93.6k -93,641 -51.8%
27 BETA BIONICS INC COM BBNX BBNX 1,249,441 $19.6m1.07% 1.07% ReducedShares held: Q3 2025 0, Q4 2025 678.3k, Q1 2026 1.4m, Q2 2026 1.2m -165.4k -165,397 -11.7%
28 COGENT BIOSCIENCES INC COM COGT COGT 490,235 $19.0m1.03% 1.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 490.2k
29 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,865,653 $18.7m1.02% 1.02% ReducedShares held: Q3 2025 1.4m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 1.9m -1.2m -1,174,167 -38.6%
30 MOLINA HEALTHCARE INC COM MOH MOH 80,594 $18.4m1.00% 1.00% AddedShares held: Q3 2025 9.5k, Q4 2025 45.5k, Q1 2026 32.8k, Q2 2026 80.6k +47.8k +47,783 145.6%
31 PENNANT GROUP INC COM PNTG PNTG 460,272 $17.0m0.93% 0.93% AddedShares held: Q3 2025 38.0k, Q4 2025 294.0k, Q1 2026 312.2k, Q2 2026 460.3k +148.1k +148,094 47.4%
32 LTC PPTYS INC COM LTC LTC 420,640 $16.2m0.88% 0.88% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 321.0k, Q2 2026 420.6k +99.6k +99,594 31.0%
33 INSMED INC COM PAR $.01 INSM INSM 149,209 $15.9m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 149.2k
34 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 831,142 $15.3m0.83% 0.83% AddedShares held: Q3 2025 1.9m, Q4 2025 1.8m, Q1 2026 713.3k, Q2 2026 831.1k +117.9k +117,873 16.5%
35 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 249,607 $14.3m0.78% 0.78% AddedShares held: Q3 2025 146.6k, Q4 2025 93.7k, Q1 2026 207.8k, Q2 2026 249.6k +41.8k +41,839 20.1%
36 AMN HEALTHCARE SVCS INC COM AMN AMN 428,531 $13.9m0.76% 0.76% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 428.5k
37 CELCUITY INC COM CELC CELC 127,931 $13.4m0.73% 0.73% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 127.9k
38 PHARVARIS N V COM PHVS PHVS 386,383 $13.4m0.73% 0.73% ReducedShares held: Q3 2025 0, Q4 2025 439.2k, Q1 2026 407.0k, Q2 2026 386.4k -20.6k -20,577 -5.1%
39 CYTOMX THERAPEUTICS INC COM CTMX CTMX 3,558,497 $13.3m0.73% 0.73% AddedShares held: Q3 2025 0, Q4 2025 2.5m, Q1 2026 3.2m, Q2 2026 3.6m +370.0k +369,983 11.6%
40 HUMANA INC COM HUM HUM 31,171 $12.4m0.67% 0.67% NewShares held: Q3 2025 16.7k, Q4 2025 32.5k, Q1 2026 0, Q2 2026 31.2k
41 XENON PHARMACEUTICALS INC COM XENE XENE 196,532 $11.9m0.65% 0.65% AddedShares held: Q3 2025 0, Q4 2025 231.4k, Q1 2026 129.6k, Q2 2026 196.5k +67.0k +66,958 51.7%
42 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 747,994 $11.2m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 748.0k
43 ASCENDIS PHARMA A/S ORD SHS ASND ASND 41,621 $11.1m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 41.6k
44 BRUKER CORP COM BRKR BRKR 182,894 $11.0m0.60% 0.60% AddedShares held: Q3 2025 687.1k, Q4 2025 783.8k, Q1 2026 117.0k, Q2 2026 182.9k +65.9k +65,881 56.3%
45 MODERNA INC COM MRNA MRNA 152,122 $10.7m0.58% 0.58% ReducedShares held: Q3 2025 0, Q4 2025 267.8k, Q1 2026 159.7k, Q2 2026 152.1k -7.6k -7,586 -4.8%
46 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 196,302 $10.5m0.57% 0.57% AddedShares held: Q3 2025 166.4k, Q4 2025 127.6k, Q1 2026 138.0k, Q2 2026 196.3k +58.3k +58,266 42.2%
47 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 217,185 $10.2m0.56% 0.56% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 160.7k, Q2 2026 217.2k +56.5k +56,462 35.1%
48 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 672,825 $9.5m0.52% 0.52% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 677.9k, Q2 2026 672.8k -5.1k -5,099 -0.8%
49 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 275,471 $9.3m0.51% 0.51% ReducedShares held: Q3 2025 488.6k, Q4 2025 420.8k, Q1 2026 285.8k, Q2 2026 275.5k -10.3k -10,293 -3.6%
50 REVVITY INC COM RVTY RVTY 83,624 $9.3m0.51% 0.51% ReducedShares held: Q3 2025 394.3k, Q4 2025 162.8k, Q1 2026 84.9k, Q2 2026 83.6k -1.2k -1,230 -1.4%
51 PALISADE BIO INC COM PALI PALI 4,182,785 $8.7m0.48% 0.48% ReducedShares held: Q3 2025 0, Q4 2025 5.4m, Q1 2026 5.0m, Q2 2026 4.2m -804.7k -804,714 -16.1%
52 ARDELYX INC COM ARDX ARDX 1,678,345 $8.6m0.47% 0.47% ReducedShares held: Q3 2025 1.4m, Q4 2025 1.7m, Q1 2026 2.2m, Q2 2026 1.7m -551.1k -551,101 -24.7%
53 MINERALYS THERAPEUTICS INC COM MLYS MLYS 309,689 $8.4m0.46% 0.46% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 309.7k
54 RELAY THERAPEUTICS INC COM RLAY RLAY 434,314 $8.1m0.44% 0.44% AddedShares held: Q3 2025 479.1k, Q4 2025 489.1k, Q1 2026 270.7k, Q2 2026 434.3k +163.6k +163,609 60.4%
55 NOVO-NORDISK A S ADR NVO NVO 169,227 $8.1m0.44% 0.44% NewShares held: Q3 2025 217.7k, Q4 2025 0, Q1 2026 0, Q2 2026 169.2k
56 BIOHAVEN LTD COM BHVN BHVN 515,804 $7.7m0.42% 0.42% NewShares held: Q3 2025 0, Q4 2025 145.4k, Q1 2026 0, Q2 2026 515.8k
57 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 58,504 $7.2m0.39% 0.39% NewShares held: Q3 2025 0, Q4 2025 53.0k, Q1 2026 0, Q2 2026 58.5k
58 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 136,631 $6.9m0.38% 0.38% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 136.6k
59 REPLIMUNE GROUP INC COM REPL REPL 590,252 $6.5m0.36% 0.36% AddedShares held: Q3 2025 60.0k, Q4 2025 0, Q1 2026 334.9k, Q2 2026 590.3k +255.4k +255,391 76.3%
60 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 183,663 $6.0m0.32% 0.32% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.2k, Q2 2026 183.7k +83.5k +83,465 83.3%
61 BEAM THERAPEUTICS INC COM BEAM BEAM 166,289 $5.7m0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 166.3k
62 NATIONAL HEALTH INVS INC COM NHI NHI 70,673 $5.4m0.29% 0.29% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 70.7k
63 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 154,130 $5.1m0.28% 0.28% AddedShares held: Q3 2025 0, Q4 2025 317.2k, Q1 2026 62.6k, Q2 2026 154.1k +91.6k +91,555 146.3%
64 PACS GROUP INC COM SHS PACS PACS 117,441 $5.0m0.27% 0.27% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 117.4k
65 EQUILLIUM INC COM EQ EQ 1,520,824 $4.9m0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.5m +21.8k +21,831 1.5%
66 ANAPTYSBIO INC COM ANAB ANAB 69,983 $4.7m0.26% 0.26% AddedShares held: Q3 2025 0, Q4 2025 120.9k, Q1 2026 27.1k, Q2 2026 70.0k +42.9k +42,894 158.3%
67 NATIONAL HEALTHCARE CORP COM NHC NHC 22,116 $4.7m0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 28.6k, Q1 2026 0, Q2 2026 22.1k
68 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 297,735 $4.3m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 297.7k
69 SONIDA SENIOR LIVING INC COM SNDA SNDA 102,624 $4.2m0.23% 0.23% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.4k, Q2 2026 102.6k +74.2k +74,187 260.9%
70 GLAUKOS CORP COM GKOS GKOS 29,343 $4.1m0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 147.5k, Q1 2026 60.2k, Q2 2026 29.3k -30.9k -30,871 -51.3%
71 AGILON HEALTH INC COM NEW AGL AGL 37,792 $4.1m0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 176.6k, Q2 2026 37.8k -138.8k -138,796 -78.6%
72 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 135,355 $3.5m0.19% 0.19% ReducedShares held: Q3 2025 111.5k, Q4 2025 434.6k, Q1 2026 576.6k, Q2 2026 135.4k -441.2k -441,225 -76.5%
73 TARSUS PHARMACEUTICALS INC COM TARS TARS 55,710 $3.5m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.7k
74 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 128,286 $3.4m0.18% 0.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 125.2k, Q2 2026 128.3k +3.1k +3,118 2.5%
75 ARS PHARMACEUTICALS INC COM SPRY SPRY 377,007 $3.0m0.16% 0.16% AddedShares held: Q3 2025 976.5k, Q4 2025 251.6k, Q1 2026 136.2k, Q2 2026 377.0k +240.8k +240,772 176.7%
76 INFLARX NV COM IFRX IFRX 1,304,069 $2.9m0.16% 0.16% ReducedShares held: Q3 2025 1.7m, Q4 2025 1.8m, Q1 2026 1.8m, Q2 2026 1.3m -454.5k -454,504 -25.9%
77 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 7,241 $2.9m0.16% 0.16% ReducedShares held: Q3 2025 14.4k, Q4 2025 18.1k, Q1 2026 11.1k, Q2 2026 7.2k -3.9k -3,878 -34.9%
78 ALECTOR INC COM ALEC ALEC 1,423,873 $2.9m0.16% 0.16% AddedShares held: Q3 2025 1.5m, Q4 2025 1.0m, Q1 2026 1.4m, Q2 2026 1.4m +72.8k +72,767 5.4%
79 VOR BIOPHARMA INC COM NEW VOR VOR 149,681 $2.8m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 149.7k
80 DESIGN THERAPEUTICS INC COM DSGN DSGN 190,000 $2.7m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 190.0k
81 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 276,174 $2.7m0.15% 0.15% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 276.2k, Q2 2026 276.2k
82 PMV PHARMACEUTICALS INC COM PMVP PMVP 1,890,904 $2.5m0.14% 0.14% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.3m, Q2 2026 1.9m -457.5k -457,456 -19.5%
83 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 148,017 $2.4m0.13% 0.13% AddedShares held: Q3 2025 134.6k, Q4 2025 137.5k, Q1 2026 146.4k, Q2 2026 148.0k +1.6k +1,606 1.1%
84 EVOMMUNE INC COM SHS EVMN EVMN 174,460 $2.3m0.13% 0.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 54.7k, Q2 2026 174.5k +119.8k +119,780 219.1%
85 AMARIN CORP PLC SPONSORED ADR AMRN AMRN 145,296 $2.3m0.13% 0.13% ReducedShares held: Q3 2025 167.3k, Q4 2025 172.2k, Q1 2026 147.7k, Q2 2026 145.3k -2.4k -2,419 -1.6%
86 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 40,000 $2.2m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 40.0k
87 REPLIGEN CORP COM RGEN RGEN 14,401 $2.0m0.11% 0.11% ReducedShares held: Q3 2025 105.1k, Q4 2025 0, Q1 2026 120.8k, Q2 2026 14.4k -106.4k -106,384 -88.1%
88 INVIVYD INC COM IVVD IVVD 2,237,015 $2.0m0.11% 0.11% ReducedShares held: Q3 2025 2.0m, Q4 2025 2.1m, Q1 2026 2.3m, Q2 2026 2.2m -39.3k -39,334 -1.7%
89 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,022,265 $1.9m0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
90 GRACE THERAPEUTICS INC COM GRCE GRCE 772,900 $1.8m0.10% 0.10% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 756.6k, Q2 2026 772.9k +16.3k +16,300 2.1%
91 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 166,229 $1.6m0.09% 0.09% ReducedShares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 401.2k, Q2 2026 166.2k -235.0k -234,958 -58.6%
92 VIR BIOTECHNOLOGY INC COM VIR VIR 156,636 $1.6m0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 250.0k, Q2 2026 156.6k -93.4k -93,364 -37.4%
93 EDITAS MEDICINE INC COM EDIT EDIT 458,809 $1.5m0.08% 0.08% AddedShares held: Q3 2025 0, Q4 2025 290.9k, Q1 2026 290.9k, Q2 2026 458.8k +167.9k +167,890 57.7%
94 AADI BIOSCIENCE INC COM WHWK WHWK 303,306 $1.4m0.08% 0.08% ReducedShares held: Q3 2025 0, Q4 2025 260.3k, Q1 2026 306.8k, Q2 2026 303.3k -3.5k -3,494 -1.1%
95 BIO-TECHNE CORP COM TECH TECH 19,308 $1.4m0.07% 0.07% ReducedShares held: Q3 2025 591.5k, Q4 2025 377.4k, Q1 2026 125.9k, Q2 2026 19.3k -106.6k -106,588 -84.7%
96 REVOLUTION MEDICINES INC COM RVMD RVMD 6,943 $1.3m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.9k
97 SAVARA INC COM SVRA SVRA 204,428 $1.3m0.07% 0.07% ReducedShares held: Q3 2025 0, Q4 2025 170.2k, Q1 2026 384.3k, Q2 2026 204.4k -179.8k -179,836 -46.8%
98 SURROZEN INC COM NEW SRZN SRZN 47,777 $1.2m0.07% 0.07% ReducedShares held: Q3 2025 77.0k, Q4 2025 95.3k, Q1 2026 58.6k, Q2 2026 47.8k -10.8k -10,847 -18.5%
99 INOVIO PHARMACEUTICALS INC COM SHS INO INO 1,035,360 $1.1m0.06% 0.06% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
100 PLIANT THERAPEUTICS INC COM PLRX PLRX 891,425 $1.0m0.06% 0.06% UnchangedShares held: Q3 2025 824.6k, Q4 2025 842.0k, Q1 2026 891.4k, Q2 2026 891.4k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
HEALTHPEAK PROPERTIES INC DOC DOC 1,981,070 $32.5m2.0m shares
AVANTOR INC AVTR AVTR 2,974,287 $23.3m3.0m shares
QIAGEN NV QGEN QGEN 545,330 $21.8m545.3k shares
ICON PLC ICLR ICLR 68,688 $7.6m68.7k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 200,000 $6.8m200.0k shares
MADRIGAL PHARMACEUTICALS INC MDGL MDGL 10,000 $5.2m10.0k shares
ESPERION THERAPEUTICS INC NE ESPR ESPR 1,735,963 $4.8m1.7m shares
HEALTHEQUITY INC HQY HQY 51,614 $4.3m51.6k shares
DAY ONE BIOPHARMACEUTICALS I 183,902 $3.9m183.9k shares
CENTENE CORP DEL CNC CNC 111,652 $3.7m111.7k shares
ENGENE HOLDINGS INC 510,543 $3.5m510.5k shares
ENHABIT INC EHAB EHAB 227,451 $3.2m227.5k shares
SUTRO BIOPHARMA INC STRO STRO 73,161 $1.8m73.2k shares
NOVOCURE LTD NVCR NVCR 134,917 $1.5m134.9k shares
BIOVENTUS INC BVS BVS 159,110 $1.5m159.1k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 39,238 $1.2m39.2k shares
TYRA BIOSCIENCES INC TYRA TYRA 27,055 $1.0m27.1k shares
PASSAGE BIO INC PASG PASG 131,581 $1.0m131.6k shares
DIVERSIFIED HEALTHCARE TR DHC DHC 151,283 $1.0m151.3k shares
INMODE LTD INMD INMD 67,744 $926.7k67.7k shares
AIRSCULPT TECHNOLOGIES INC AIRS AIRS 74,139 $209.8k74.1k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 98,600 $72.6m98.6k shares Reduced
INSMED INC INSM · Call INSMCall 96,600 $10.3m96.6k shares Added
SPDR SER TR XBI · Put XBIPut 31,000 $4.9m31.0k shares Added
UNIVERSAL HLTH SVCS INC UHS · Put UHSPut 18,800 $2.8m18.8k shares Added
QIAGEN NV QGEN · Call QGENCall 68,100 $2.7m68.1k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17